Market: HKEX |
Currency: HKD
Address: 288 Fute Zhong Road
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; and drug discovery services to pharmaceutical and biotech customers. In addition, the company offers consulting services for combinatorial chemistry and pharmaceuticals; and develops computer software and databases. Further, it is involved in pharmaceutical research and development; pharmacology, toxicology, and safety evaluation research services; and new drug clinical development and on-site management services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Show more
📈 WuXi AppTec Co., Ltd. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$123.19
-
Upside/Downside from Analyst Target:
15.56%
-
Broker Call:
29
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2025-10-27
-
EPS Estimate:
1.03
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.376770 |
- |
2025-05-15 |
- |
Dividend payout |
| $0.378910 |
- |
2025-05-12 |
- |
Dividend payout |
|
Total Amount for 2025: $0.755680 |
| 2024 |
- |
$1.087000 |
- |
2024-06-17 |
- |
Dividend payout |
|
Total Amount for 2024: $1.087000 |
| 2023 |
- |
$0.988910 |
- |
2023-06-05 |
- |
Dividend payout |
|
Total Amount for 2023: $0.988910 |
| 2022 |
- |
$0.616300 |
- |
2022-05-30 |
- |
Dividend payout |
|
Total Amount for 2022: $0.616300 |
| 2021 |
- |
$0.364583 |
- |
2021-05-28 |
- |
Dividend payout |
| $1.200000 |
- |
2021-05-28 |
- |
Stock split |
|
Total Amount for 2021: $1.564583 |
📅 Earnings & EPS History for WuXi AppTec Co., Ltd.
| Date | Reported EPS |
|---|
| 2025-10-27 (estimated upcoming) | - |
| 2025-07-28 | 1.66 |
| 2025-04-28 | 1.24 |
| 2025-03-17 | 0.98 |
| 2024-10-28 | 0.79 |
| 2024-07-29 | 0.79 |
| 2024-04-29 | 0.66 |
| 2024-03-18 | 0.88 |
| 2023-10-30 | 0.94 |
| 2023-07-31 | 1.07 |
| 2023-04-24 | 0.72 |
| 2023-03-20 | 0.49 |
| 2022-10-26 | 0.81 |
| 2022-07-26 | 0.95 |
| 2022-04-25 | 0.53 |
| 2022-02-15 | 0.54 |
| 2021-10-29 | 0.3 |
| 2021-08-12 | 0.41 |
| 2021-04-29 | 0.51 |
| 2021-03-30 | 0.2 |
| 2020-10-29 | 0.23 |
| 2020-07-20 | 0.51 |
| 2020-04-29 | 0.11 |
| 2020-03-24 | 0.03 |
| 2019-10-30 | 0.24 |
📰 Related News & Research
-
WuXi AppTec (2359 HK) Delivers Strong 1H25 Results: Revenue Jumps 20.6%, Ups Guidance, Target Price HK$146 – Buy Recommendation
July 30, 2025
UOB Kay Hian Date of Report: July 30, 2025 WuXi AppTec Surges on Robust 1H25 Results: Strong Growth in CRDMO Services and TIDES Business Drives…
-
Global Market Pulse: Tech Earnings, Trade Tariffs & Top Investment Ideas – WuXi AppTec, CapitaLand China Trust, and More (July 2025)
July 23, 2025
OCBC Investment Research 23 July 2025 Global Market Pulse: Key Earnings, Defensive Rotations, and Top Stock Picks for 2025 Market Overview: Investors Rotate into Defensives…
-
WuXi AppTec (603259.SS) Stock Analysis 2025: Strong Earnings, Growth Outlook & Investment Potential
July 23, 2025
Broker: OCBC Investment Research Date of Report: 22 July 2025 WuXi AppTec: Riding the Wave of Global Pharma Outsourcing with Robust Growth and Rising Margins…
-
WuXi AppTec Boosts Investor Confidence Amidst Legislative Uncertainty and Strong Growth Prospects
October 3, 2024
Date: October 2, 2024Broker: OCBC Investment Research Company Overview WuXi AppTec, founded in 2000, is a global leader in contract research, development, and manufacturing (CRDMO).…
-
WuXi AppTec Surges Amid Investor Optimism and Robust Growth Outlook
October 2, 2024
Date of Report: 2 October 2024Broker: OCBC Investment Research Company Overview WuXi AppTec, founded in 2000, is a leading global contract research, development, and manufacturing…
-
WuXi AppTec: Growth Amid Geopolitical Challenges
September 11, 2024
WuXi AppTec: Growth Amid Geopolitical Challenges Overview: WuXi AppTec (603259.SS) is a leading global pharmaceutical contract research, development, and manufacturing organization (CRDMO). Founded in 2000,…
-
Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals
September 2, 2024
Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals 🏢 Sino Biopharmaceutical (1177 HK) – Leading the Charge with Innovative Drug Development…
🔍 View more Reports
